查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611232

血液检测市场规模、份额、趋势分析报告：按测试类型、地区、细分市场预测，2025-2030 年

Blood Testing Market Size, Share & Trends Analysis Report By Test Type (Glucose, Lipid, COVID-19, A1C, CRP, Vitamin-D, ALT, AST, Thyroid Stimulating Hormone, PSA, Cortisol), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

血液检测市场的成长和趋势

Grand View Research, Inc.最新报告显示，预计2030年全球血液检测市场规模将达到1,605亿美元，2025年至2030年复合年增长率为8.83%。该市场的成长归因于多种因素，包括对传染源识别的需求不断增加以及政府和监管机构医疗保健支出的增加。此外，糖尿病、COVID-19 和心血管疾病等感染疾病等传染病率的上升预计将推动市场成长。例如，根据美国疾病管制与预防中心的数据，2022年美国约有3,730万人被诊断出患有糖尿病，占总人口的11.3%。

糖尿病盛行率的不断上升创造了对血液检测的巨大需求，并促进了市场的成长。此外，用于血液检测的产品的技术进步正在推动市场的成长。携带式血糖仪的出现使患者可以随时随地方便地进行常规检查，这有助于市场的成长。此外，糖尿病患者在手术前进行糖尿病监测非常重要，这进一步推动了对这些产品的需求。预计新产品的采用将在预测期内推动市场成长。

例如，2022 年 5 月，Labcorp 透过 Labcorp OnDemand 推出了一款家用采集套件。该套件允许个人从少量血液样本中测量糖化血红蛋白 (HbA1c) 值并监测血糖水平。美国红十字会、纽约血液中心、美国血液中心、武装部队血液计画、AABB 和美国血液中心等领先组织在提供有关血浆采集和捐赠的资讯方面发挥着重要作用。捐血的增加预计将进一步推动对移植前和移植后程序中使用的检测产品的需求，从而促进市场成长。

血液检测市场报告亮点

  • 2024 年，血糖测试领域占据最大的收益占有率。支持这一细分市场成长的是 I 型和 II 型糖尿病盛行率的增加以及与遗传性糖尿病相关的病例数量的增加。
  • 技术的不断进步促进了创新血液检测方法和设备的发展。就地检验、穿戴式装置和改进的实验室测试技术等进步正在推动市场成长。
  • 北美地区在 2024 年占据最大的收益占有率，预计在预测期内将保持其地位，而亚太地区预计将在 2025 年至 2030 年期间出现显着增长。
  • 该行业的主要参与企业正专注于产品发布和地理扩张，以维持其影响力。例如，2023 年 3 月，苹果在非侵入性血糖监测技术的开发方面取得了显着进展，允许患有糖尿病和其他疾病的个人血糖值，而无需进行皮肤刺痛或传统的血液检测方法。可以测量它。
  • 2022 年 6 月，阿波罗癌症中心与 Datar Cancer Genetics 合作，宣布进行一项血液检测，可检测无症状族群的早期乳癌。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 工业分析工具
    • 波特五力分析
    • PESTEL分析

第四章 采血点经营分析

  • 血液检测市场：采血地点仪表板
  • 血液检测市场：采血地点变化分析
  • 血液检测市场（依采集地点、收益）
  • 血糖测试
    • 2018-2030年血糖检测市场
  • A1C测试
    • A1C测试市场，2018-2030
  • 直接低密度脂蛋白测试
    • 直接 LDL 检测市场，2018-2030 年
  • 血脂检查
    • 血脂检查市场，2018-2030
  • 摄护腺特异性抗原检测
    • 前列腺特异性抗原检测市场，2018-2030
  • COVID-19 测试
    • COVID-19 测试市场，2018-2030
  • 尿素氮检查
    • BUN 测试市场，2018-2030
  • 维生素D测试
    • 维生素 D 测试市场，2018-2030
  • 甲状腺刺激素（TSH）测试
    • 甲状腺刺激素（TSH）检测市场，2018-2030
  • 血清尼古丁/可替宁测试
    • 血清尼古丁/可替宁测试市场，2018-2030
  • 高灵敏度CRP测试
    • 高灵敏度CRP检测市场，2018-2030年
  • 睪酮测试
    • 测试类固醇测试市场，2018-2030
  • 丙氨酸转氨酶测试
    • ALT 测试市场，2018-2030
  • 皮质醇测试
    • 皮质醇测试市场，2018-2030
  • 肌酸酐测试
    • 肌酸酐检测市场，2018-2030
  • 谷草转氨酶测试
    • AST 测试市场，2018-2030
  • 其他血液检查
    • 其他血液检测市场，2018-2030

第五章区域业务分析

  • 2024 年和 2030 年按地区分類的血液检测市场占有率
  • 北美洲
    • 北美血液检测市场，2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲血液检测市场，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
    • 俄罗斯
  • 亚太地区
    • 亚太血液检测市场，2018-2030
    • 中国
    • 印度
    • 日本
    • 泰国
    • 韩国
    • 新加坡
  • 拉丁美洲
    • 拉丁美洲血液检测市场，2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 中东和非洲血液检测市场，2018-2030
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争状况

  • 公司分类
  • 策略规划
  • 2024 年企业市场占有率分析
  • 公司简介/上市公司
    • Abbott
    • bioMerieux
    • Quest Diagnostics Incorporated
    • Biomerica, Inc
    • BD
    • QIAGEN Siemens Healthineers AG
    • Danaher Corporation
    • Trinity BIoTech Plc
Product Code: 978-1-68038-897-8

Blood Testing Market Growth & Trends:

The global blood testing market size is estimated to reach USD 160.50 billion by 2030, registering a CAGR of 8.83% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributable to various factors including the growing demand for the identification of infectious agents and increased healthcare spending by government and regulatory bodies. Furthermore, the rising prevalence of infectious diseases, such as diabetes, COVID-19, and cardiovascular diseases, is anticipated to drive market growth. For instance, according to the CDC in 2022, approximately 37.3 million people were diagnosed with diabetes in the United States, accounting for 11.3 % of the population.

This increasing prevalence of diabetes creates a significant demand for blood tests, thus contributing to the growth of the market. Furthermore, technological advancement in the products used for blood testing fuels the growth of the market. The availability of portable glucose meters that enable patients to perform routine checkups conveniently and anywhere has contributed to an expansion of the market. In addition, the monitoring of diabetes is crucial prior to any surgical intervention for patients with diabetes, which further drives the demand for these products. The introduction of new products is anticipated to fuel market growth over the projection period.

For instance, in May 2022, Labcorp introduced an at-home collection kit with Labcorp OnDemand, which allows individuals to measure their hemoglobin A1c (HbA1c) levels from a small blood sample to monitor their sugar levels. Key organizations, such as the American Red Cross, the New York Blood Center, America's Blood Centers, Armed Services Blood Program, AABB, and Blood Centers of America, play a crucial role in providing information on plasma collection and delivery. The rise in blood donations is expected to further drive the demand for testing products used in pre-transplant and post-transplant procedures, thereby boosting market growth.

Blood Testing Market Report Highlights:

  • The glucose testing segment held the largest revenue share in 2024. The segment growth is supported by the increasing prevalence of both type I and type II diabetes, along with the growing number of cases related to hereditary diabetes
  • Continuous advancements in technology have led to the development of innovative blood testing methods and devices. These advancements, such as point-of-care testing, wearable devices, and improved laboratory testing techniques, drive market growth.
  • North America held the largest revenue share in 2024 and is expected to maintain its position throughout the forecast period; however, Asia Pacific is expected to grow at a significant rate from 2025 to 2030
  • Key players operating are focusing on product launches and geographical expansion to maintain their presence. For instance, in March 2023, Apple made notable progress in the development of non-invasive blood glucose monitoring technology, enabling individuals with diabetes and other conditions to measure their blood glucose levels without the need for skin pricks or traditional blood testing methods
  • In June 2022, Apollo Cancer Centers, in collaboration with Datar Cancer Genetics, introduced a blood test capable of detecting early-stage breast cancers in asymptomatic individuals.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Formulation & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objective
    • 1.9.1. Objective 1
    • 1.9.2. Objective2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing prevalence of target disease
      • 3.2.1.2. Growing demand for point-of-care tests
      • 3.2.1.3. Implementation of favorable government initiatives & external funding for R&D activities
      • 3.2.1.4. Introduction of CLIA waived tests
      • 3.2.1.5. Rising demand for early disease detection
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulatory and reimbursement policies
      • 3.2.2.2. Limitations associated with blood testing
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Collection Site Business Analysis

  • 4.1. Blood Testing Market: Collection Site Dashboard
  • 4.2. Blood Testing Market: Collection Site Movement Analysis
  • 4.3. Blood Testing Market by Collection Site, Revenue
  • 4.4. Glucose Testing
    • 4.4.1. Glucose Testing Market, 2018 - 2030 (USD Million)
  • 4.5. A1C Testing
    • 4.5.1. A1C Testing Market, 2018 - 2030 (USD Million)
  • 4.6. Direct LDL Testing
    • 4.6.1. Direct LDL Testing Market, 2018 - 2030 (USD Million)
  • 4.7. Lipid Panel Testing
    • 4.7.1. Lipid Panel Testing Market, 2018 - 2030 (USD Million)
  • 4.8. Prostate Specific Antigen Testing
    • 4.8.1. Prostate Specific Antigen Testing Market, 2018 - 2030 (USD Million)
  • 4.9. COVID-19 Testing
    • 4.9.1. COVID-19 Testing Market, 2018 - 2030 (USD Million)
  • 4.10. BUN Testing
    • 4.10.1. BUN Testing Market, 2018 - 2030 (USD Million)
  • 4.11. Vitamin D Testing
    • 4.11.1. Vitamin D Testing Market, 2018 - 2030 (USD Million)
  • 4.12. Thyroid Stimulating Hormone (TSH) Testing
    • 4.12.1. Thyroid Stimulating Hormone (TSH) Testing Market, 2018 - 2030 (USD Million)
  • 4.13. Serum Nicotine/Cotinine Testing
    • 4.13.1. Serum Nicotine/Cotinine Testing Market, 2018 - 2030 (USD Million)
  • 4.14. High Sensitivity CRP Testing
    • 4.14.1. High Sensitivity CRP Testing Market, 2018 - 2030 (USD Million)
  • 4.15. Testosterone Testing
    • 4.15.1. Testosterone Testing Market, 2018 - 2030 (USD Million)
  • 4.16. ALT Testing
    • 4.16.1. ALT Testing Market, 2018 - 2030 (USD Million)
  • 4.17. Cortisol Testing
    • 4.17.1. Cortisol Testing Market, 2018 - 2030 (USD Million)
  • 4.18. Creatinine Testing
    • 4.18.1. Creatinine Testing Market, 2018 - 2030 (USD Million)
  • 4.19. AST Testing
    • 4.19.1. AST Testing Market, 2018 - 2030 (USD Million)
  • 4.20. Other Blood Tests
    • 4.20.1. Other Blood Tests Market, 2018 - 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Blood Testing Market Share By Region, 2024 & 2030
  • 5.2. North America
    • 5.2.1. North America Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. Key Country Dynamics
      • 5.2.2.2. Competitive Scenario
      • 5.2.2.3. Regulatory Framework
      • 5.2.2.4. U.S. Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.2.3. Canada
      • 5.2.3.1. Key Country Dynamics
      • 5.2.3.2. Competitive Scenario
      • 5.2.3.3. Regulatory Framework
      • 5.2.3.4. Canada Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.2.4. Mexico
      • 5.2.4.1. Key Country Dynamics
      • 5.2.4.2. Competitive Scenario
      • 5.2.4.3. Regulatory Framework
      • 5.2.4.4. Mexico Blood Testing Market, 2018 - 2030 (USD Million)
  • 5.3. Europe
    • 5.3.1. Europe Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.2. UK
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Competitive Scenario
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. UK Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.3. Germany
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Competitive Scenario
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Germany Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.4. France
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Competitive Scenario
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. France Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.5. Italy
      • 5.3.5.1. Key Country Dynamics
      • 5.3.5.2. Competitive Scenario
      • 5.3.5.3. Regulatory Framework
      • 5.3.5.4. Italy Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.6. Spain
      • 5.3.6.1. Key Country Dynamics
      • 5.3.6.2. Competitive Scenario
      • 5.3.6.3. Regulatory Framework
      • 5.3.6.4. Spain Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.7. Sweden
      • 5.3.7.1. Key Country Dynamics
      • 5.3.7.2. Competitive Scenario
      • 5.3.7.3. Regulatory Framework
      • 5.3.7.4. Sweden Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.8. Norway
      • 5.3.8.1. Key Country Dynamics
      • 5.3.8.2. Competitive Scenario
      • 5.3.8.3. Regulatory Framework
      • 5.3.8.4. Norway Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.9. Denmark
      • 5.3.9.1. Key Country Dynamics
      • 5.3.9.2. Competitive Scenario
      • 5.3.9.3. Regulatory Framework
      • 5.3.9.4. Denmark Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.10. Russia
      • 5.3.10.1. Key Country Dynamics
      • 5.3.10.2. Competitive Scenario
      • 5.3.10.3. Regulatory Framework
      • 5.3.10.4. Russia Blood Testing Market, 2018 - 2030 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.2. China
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Competitive Scenario
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. China Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.3. India
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Competitive Scenario
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. India Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.4. Japan
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Competitive Scenario
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. Japan Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.5. Thailand
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Competitive Scenario
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Thailand Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.6. South Korea
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Competitive Scenario
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. South Korea Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.7. Singapore
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Competitive Scenario
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Singapore Blood Testing Market, 2018 - 2030 (USD Million)
  • 5.5. Latin America
    • 5.5.1. Latin America Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.5.2. Brazil
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Brazil Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.5.3. Argentina
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Argentina Blood Testing Market, 2018 - 2030 (USD Million)
  • 5.6. MEA
    • 5.6.1. MEA Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.6.2. Saudi Arabia
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Saudi Arabia Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.6.3. South Africa
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. South Africa Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.6.4. UAE
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Competitive Scenario
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. UAE Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.6.5. Kuwait
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Competitive Scenario
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Kuwait Blood Testing Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Market Share Analysis, 2024
  • 6.4. Company Profiles/Listing
    • 6.4.1. Abbott
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.1.3. Collection Site Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. bioMerieux
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.2.3. Collection Site Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Quest Diagnostics Incorporated
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.3.3. Collection Site Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. Biomerica, Inc
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.4.3. Collection Site Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. BD
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.5.3. Collection Site Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. QIAGEN Siemens Healthineers AG
      • 6.4.6.1. Overview
      • 6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.6.3. Collection Site Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Danaher Corporation
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.7.3. Collection Site Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Trinity Biotech Plc
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.8.3. Collection Site Benchmarking
      • 6.4.8.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Blood Testing Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 5 North America Blood Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 6 North America Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 8 Canada Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 9 Mexico Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 10 Europe Blood Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 11 Europe Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 12 France Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 13 Germany Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 14 UK Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 15 Spain Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 16 France Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 17 Italy Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 18 Sweden Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 19 Norway Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 20 Denmark Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific Blood Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Asia Pacific Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 23 Japan Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 24 China Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 25 India Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 26 South Korea Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 27 Australia Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 28 Thailand Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 29 Latin America Blood Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 30 Latin America Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 31 Brazil Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 32 Argentina Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 33 MEA Blood Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 34 MEA Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 35 South Africa Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 36 Saudi Arabia Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 37 UAE Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 38 Kuwait Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Blood Testing Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Blood testing market: Testing type outlook and key takeaways
  • Fig. 15 Blood testing market: Testing type movement analysis & market share 2024 & 2030
  • Fig. 16 Glucose testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 A1C testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Direct LDL testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Lipid panel testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 PSA testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 COVID-19 testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 BUN testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Vitamin D testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 TSH testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Serum nicotine/cotinine testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 CRP testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Testosterone testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 ALT testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Cortisol testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Creatinine testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 AST testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Other blood testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Regional Outlook, 2024 & 2030
  • Fig. 34 Regional Market Dashboard
  • Fig. 35 Regional Market Place: Key Takeaways
  • Fig. 36 North America, SWOT Analysis
  • Fig. 37 Europe, SWOT Analysis
  • Fig. 38 Asia Pacific, SWOT Analysis
  • Fig. 39 Latin America, SWOT Analysis
  • Fig. 40 MEA, SWOT Analysis
  • Fig. 41 North America
  • Fig. 42 North America Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 43 U.S.
  • Fig. 44 U.S. Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Canada
  • Fig. 46 Canada Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico
  • Fig. 48 Mexico Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Europe
  • Fig. 50 Europe Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 51 UK
  • Fig. 52 UK Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Germany
  • Fig. 54 Germany Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Italy
  • Fig. 56 Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 57 France
  • Fig. 58 France Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Spain
  • Fig. 60 Spain Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Sweden
  • Fig. 62 Sweden Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Norway
  • Fig. 64 Norway Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Denmark
  • Fig. 66 Denmark Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Asia Pacific
  • Fig. 68 Asia-Pacific Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 69 China
  • Fig. 70 China Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 71 India
  • Fig. 72 India Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Japan
  • Fig. 74 Japan Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Australia
  • Fig. 76 Australia Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Thailand
  • Fig. 78 Thailand Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 79 South Korea
  • Fig. 80 South Korea Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America
  • Fig. 82 Latin America Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil
  • Fig. 84 Brazil Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Argentina
  • Fig. 86 Argentina Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 87 MEA
  • Fig. 88 MEA Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 89 UAE
  • Fig. 90 UAE Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 91 South Africa
  • Fig. 92 South Africa Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Saudi Arabia
  • Fig. 94 Saudi Arabia Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Kuwait
  • Fig. 96 Kuwait Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Strategy Mapping